407 related articles for article (PubMed ID: 19594898)
1. Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer.
Pietrowska M; Marczak L; Polanska J; Behrendt K; Nowicka E; Walaszczyk A; Chmura A; Deja R; Stobiecki M; Polanski A; Tarnawski R; Widlak P
J Transl Med; 2009 Jul; 7():60. PubMed ID: 19594898
[TBL] [Abstract][Full Text] [Related]
2. Optimizing of MALDI-ToF-based low-molecular-weight serum proteome pattern analysis in detection of breast cancer patients; the effect of albumin removal on classification performance.
Pietrowska M; Marczak L; Polanska J; Nowicka E; Behrent K; Tarnawski R; Stobiecki M; Polanski A; Widlak P
Neoplasma; 2010; 57(6):537-44. PubMed ID: 20845992
[TBL] [Abstract][Full Text] [Related]
3. Mass spectrometry-based analysis of therapy-related changes in serum proteome patterns of patients with early-stage breast cancer.
Pietrowska M; Polanska J; Marczak L; Behrendt K; Nowicka E; Stobiecki M; Polanski A; Tarnawski R; Widlak P
J Transl Med; 2010 Jul; 8():66. PubMed ID: 20618994
[TBL] [Abstract][Full Text] [Related]
4. Proteomic Profiling of Invasive Ductal Carcinoma (IDC) using Magnetic Beads-based Serum Fractionation and MALDI-TOF MS.
Yang J; Zhu J; He K; Zhao LY; Liu LY; Song TS; Huang C
J Clin Lab Anal; 2015 Jul; 29(4):321-7. PubMed ID: 25130542
[TBL] [Abstract][Full Text] [Related]
5. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer.
Li J; Zhang Z; Rosenzweig J; Wang YY; Chan DW
Clin Chem; 2002 Aug; 48(8):1296-304. PubMed ID: 12142387
[TBL] [Abstract][Full Text] [Related]
6. Comparison of peptide cancer signatures identified by mass spectrometry in serum of patients with head and neck, lung and colorectal cancers: association with tumor progression.
Pietrowska M; Polańska J; Suwiński R; Wideł M; Rutkowski T; Marczyk M; Domińczyk I; Ponge L; Marczak L; Polański A; Widłak P
Int J Oncol; 2012 Jan; 40(1):148-56. PubMed ID: 21894432
[TBL] [Abstract][Full Text] [Related]
7. Potential biomarkers for esophageal carcinoma detected by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Liu LH; Shan BE; Tian ZQ; Sang MX; Ai J; Zhang ZF; Meng J; Zhu H; Wang SJ
Clin Chem Lab Med; 2010 Jun; 48(6):855-61. PubMed ID: 20345231
[TBL] [Abstract][Full Text] [Related]
8. Identification of serum proteome signatures of locally advanced and metastatic gastric cancer: a pilot study.
Abramowicz A; Wojakowska A; Gdowicz-Klosok A; Polanska J; Rodziewicz P; Polanowski P; Namysl-Kaletka A; Pietrowska M; Wydmanski J; Widlak P
J Transl Med; 2015 Sep; 13():304. PubMed ID: 26376850
[TBL] [Abstract][Full Text] [Related]
9. Novel serum protein biomarker panel revealed by mass spectrometry and its prognostic value in breast cancer.
Chung L; Moore K; Phillips L; Boyle FM; Marsh DJ; Baxter RC
Breast Cancer Res; 2014 Jun; 16(3):R63. PubMed ID: 24935269
[TBL] [Abstract][Full Text] [Related]
10. Investigation of early and advanced stages in ovarian cancer using human plasma by differential scanning calorimetry and mass spectrometry.
Kim NA; Jin JH; Kim KH; Lim DG; Cheong H; Kim YH; Ju W; Kim SC; Jeong SH
Arch Pharm Res; 2016 May; 39(5):668-76. PubMed ID: 27002828
[TBL] [Abstract][Full Text] [Related]
11. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].
Zhang GQ; Du J; Pang D
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606
[TBL] [Abstract][Full Text] [Related]
12. Serum proteomic biomarker discovery reflective of stage and obesity in breast cancer patients.
Schaub NP; Jones KJ; Nyalwidhe JO; Cazares LH; Karbassi ID; Semmes OJ; Feliberti EC; Perry RR; Drake RR
J Am Coll Surg; 2009 May; 208(5):970-8; discussion 978-80. PubMed ID: 19476873
[TBL] [Abstract][Full Text] [Related]
13. The MALDI-TOF mass spectrometric view of the plasma proteome and peptidome.
Hortin GL
Clin Chem; 2006 Jul; 52(7):1223-37. PubMed ID: 16644871
[TBL] [Abstract][Full Text] [Related]
14. Identification of serum biomarkers for ovarian cancer using MALDI-TOF-MS combined with magnetic beads.
Wu S; Xu K; Chen G; Zhang J; Liu Z; Xie X
Int J Clin Oncol; 2012 Apr; 17(2):89-95. PubMed ID: 21638024
[TBL] [Abstract][Full Text] [Related]
15. Construction of a multiple myeloma diagnostic model by magnetic bead-based MALDI-TOF mass spectrometry of serum and pattern recognition software.
Wang QT; Li YZ; Liang YF; Hu CJ; Zhai YH; Zhao GF; Zhang J; Li N; Ni AP; Chen WM; Xu Y
Anat Rec (Hoboken); 2009 Apr; 292(4):604-10. PubMed ID: 19301277
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel serum peptides biomarkers for female breast cancer patients in Western China.
Yang J; Xiong X; Liu S; Zhu J; Luo M; Liu L; Zhao L; Qin Y; Song T; Huang C
Proteomics; 2016 Mar; 16(6):925-34. PubMed ID: 26705257
[TBL] [Abstract][Full Text] [Related]
17. Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples.
Freed GL; Cazares LH; Fichandler CE; Fuller TW; Sawyer CA; Stack BC; Schraff S; Semmes OJ; Wadsworth JT; Drake RR
Laryngoscope; 2008 Jan; 118(1):61-8. PubMed ID: 18043497
[TBL] [Abstract][Full Text] [Related]
18. Highly sensitive detection of melanoma based on serum proteomic profiling.
Caron J; Mangé A; Guillot B; Solassol J
J Cancer Res Clin Oncol; 2009 Sep; 135(9):1257-64. PubMed ID: 19288131
[TBL] [Abstract][Full Text] [Related]
19. High-resolution serum proteomic features for ovarian cancer detection.
Conrads TP; Fusaro VA; Ross S; Johann D; Rajapakse V; Hitt BA; Steinberg SM; Kohn EC; Fishman DA; Whitely G; Barrett JC; Liotta LA; Petricoin EF; Veenstra TD
Endocr Relat Cancer; 2004 Jun; 11(2):163-78. PubMed ID: 15163296
[TBL] [Abstract][Full Text] [Related]
20. [Search for potential gastric cancer biomarkers using low molecular weight blood plasma proteome profiling by mass spectrometry].
Shevchenko VE; Arnotskaia NE; Ogorodnikova EV; Davydov MM; Ibraev MA; Turkin IN; Davydov MI
Biomed Khim; 2014; 60(4):503-14. PubMed ID: 25249535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
